Beneficial effects of combined farnesoid X receptor agonist (INT747) and dipeptidyl peptidase-4 inhibitor (sitagliptin) on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis

被引:0
|
作者
Shimozato, Naotaka [1 ]
Namisaki, Tadashi [1 ]
Moriya, Kei [1 ]
Kitade, Mitsuteru [1 ]
Takeda, Kousuke [1 ]
Kawaratani, Hideto [1 ]
Kaji, Kosuke [1 ]
Okura, Yasushi [1 ]
Takaya, Hiroaki [1 ]
Sawada, Yasuhiko [1 ]
Nishimura, Norihisa [1 ]
Sato, Shinya [1 ]
Saikawa, Soichiro [1 ]
Seki, Kenichiro [1 ]
Furukawa, Masanori [1 ]
Nakanishi, Keisuke [1 ]
Kubo, Takuya [1 ]
Yoshiji, Hitoshi [1 ]
机构
[1] Nara Med Univ, Kashihara, Nara, Japan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2000
引用
收藏
页码:1059A / 1059A
页数:1
相关论文
共 32 条
  • [31] Mosapride, a selective serotonin 5-HT4 receptor agonist, and alogliptin, a selective dipeptidyl peptidase-4 inhibitor, exert synergic effects on plasma active GLP-1 levels and glucose tolerance in mice
    Nonogaki, Katsunori
    Kaji, Takao
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 110 (03) : E18 - E21
  • [32] COMBINED TREATMENT WITH ANTI-DIABETIC AGENTS; DIPEPTIDYL PEPTIDASE-4 INHIBITOR (DPP4-I) AND SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR (SGLT2-I) SUPPRESSES PROGRESSION IN NASH RAT MODEL
    Namisaki, Tadashi
    Ozutsumi, Takahiro
    Kaji, Kosuke
    Shimozato, Naotaka
    Saikawa, Soichiro
    Takaya, Hiroaki
    Nakanishi, Keisuke
    Tsuji, Yuki
    Sawada, Yasuhiko
    Furukawa, Masanori
    Fujinaga, Yukihisa
    Kaya, Daisuke
    Kawaratani, Hideto
    Akahane, Takemi
    Yoshiji, Hitoshi
    HEPATOLOGY, 2019, 70 : 1290A - 1290A